{"id":"https://openalex.org/W4411545401","doi":"https://doi.org/10.1016/j.clml.2025.06.018","title":"R-DA-EPOCH Versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients With Diffuse Large B-Cell Lymphoma","display_name":"R-DA-EPOCH Versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients With Diffuse Large B-Cell Lymphoma","publication_year":2025,"publication_date":"2025-06-23","ids":{"openalex":"https://openalex.org/W4411545401","doi":"https://doi.org/10.1016/j.clml.2025.06.018","pmid":"https://pubmed.ncbi.nlm.nih.gov/40681431","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13075490"},"language":"en","primary_location":{"id":"doi:10.1016/j.clml.2025.06.018","doi":"https://doi.org/10.1016/j.clml.2025.06.018","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clml.2025.06.018","pdf_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/action/showPdf?pii=S2152265025002344","source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/action/showPdf?pii=S2152265025002344","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100763133","display_name":"Benjamin J. Lee","orcid":"https://orcid.org/0000-0002-1678-1345","observed_orcids":["https://orcid.org/0000-0002-1678-1345"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210137750","display_name":"UC Irvine Health","ror":"https://ror.org/03fgher32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Benjamin J. Lee","raw_affiliation_strings":["Department of Pharmacy, University of California Irvine Health, Orange, CA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA. Electronic address: benjaml9@hs.uci.edu"],"raw_orcid":"https://orcid.org/0000-0002-1678-1345","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, University of California Irvine Health, Orange, CA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA. Electronic address: benjaml9@hs.uci.edu","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210137750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020234173","display_name":"Shawn Patrick Griffin","orcid":"https://orcid.org/0000-0002-3818-2490","observed_orcids":["https://orcid.org/0000-0002-3818-2490"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210137750","display_name":"UC Irvine Health","ror":"https://ror.org/03fgher32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shawn P. Griffin","raw_affiliation_strings":["Department of Pharmacy, University of California Irvine Health, Orange, CA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA"],"raw_orcid":"https://orcid.org/0000-0002-3818-2490","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, University of California Irvine Health, Orange, CA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210137750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074048068","display_name":"Jean Doh","orcid":"https://orcid.org/0000-0003-2737-5243","observed_orcids":["https://orcid.org/0000-0003-2737-5243"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210137750","display_name":"UC Irvine Health","ror":"https://ror.org/03fgher32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jean Doh","raw_affiliation_strings":["Department of Pharmacy, University of California Irvine Health, Orange, CA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA"],"raw_orcid":"https://orcid.org/0000-0003-2737-5243","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, University of California Irvine Health, Orange, CA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210137750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114174879","display_name":"Anthony Quach","orcid":"https://orcid.org/0000-0001-6791-2424","observed_orcids":["https://orcid.org/0000-0001-6791-2424"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210137750","display_name":"UC Irvine Health","ror":"https://ror.org/03fgher32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Quach","raw_affiliation_strings":["Department of Pharmacy, University of California Irvine Health, Orange, CA"],"raw_orcid":"https://orcid.org/0000-0001-6791-2424","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, University of California Irvine Health, Orange, CA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210137750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032084762","display_name":"Yujiao Sun","orcid":"https://orcid.org/0000-0002-5544-8713","observed_orcids":["https://orcid.org/0000-0002-5544-8713"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210137750","display_name":"UC Irvine Health","ror":"https://ror.org/03fgher32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yujiao Sun","raw_affiliation_strings":["Department of Pharmacy, University of California Irvine Health, Orange, CA"],"raw_orcid":"https://orcid.org/0000-0002-5544-8713","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, University of California Irvine Health, Orange, CA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210137750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014919457","display_name":"Elizabeth A. Brem","orcid":"https://orcid.org/0000-0002-3265-9841","observed_orcids":["https://orcid.org/0000-0002-3265-9841"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210096636","display_name":"University of California, Irvine Medical Center","ror":"https://ror.org/00cm8nm15","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096636","https://openalex.org/I4210137750"]},{"id":"https://openalex.org/I4210137750","display_name":"UC Irvine Health","ror":"https://ror.org/03fgher32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137750"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Brem","raw_affiliation_strings":["Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, CA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210096636","https://openalex.org/I4210137750","https://openalex.org/I4390039238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082758903","display_name":"Richard A. Van Etten","orcid":"https://orcid.org/0000-0003-0000-635X","observed_orcids":["https://orcid.org/0000-0003-0000-635X"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210096636","display_name":"University of California, Irvine Medical Center","ror":"https://ror.org/00cm8nm15","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096636","https://openalex.org/I4210137750"]},{"id":"https://openalex.org/I4210137750","display_name":"UC Irvine Health","ror":"https://ror.org/03fgher32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137750"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard A. Van Etten","raw_affiliation_strings":["Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, CA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210096636","https://openalex.org/I4210137750","https://openalex.org/I4390039238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086973652","display_name":"Edward L. Nelson","orcid":"https://orcid.org/0000-0001-7887-032X","observed_orcids":["https://orcid.org/0000-0001-7887-032X"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210096636","display_name":"University of California, Irvine Medical Center","ror":"https://ror.org/00cm8nm15","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096636","https://openalex.org/I4210137750"]},{"id":"https://openalex.org/I4210137750","display_name":"UC Irvine Health","ror":"https://ror.org/03fgher32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137750"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward L. Nelson","raw_affiliation_strings":["Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, CA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210096636","https://openalex.org/I4210137750","https://openalex.org/I4390039238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017578509","display_name":"Catherine Callaghan Coombs","orcid":"https://orcid.org/0000-0001-5615-2247","observed_orcids":["https://orcid.org/0000-0001-5615-2247","https://orcid.org/0000-0003-4656-7304"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210096636","display_name":"University of California, Irvine Medical Center","ror":"https://ror.org/00cm8nm15","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096636","https://openalex.org/I4210137750"]},{"id":"https://openalex.org/I4210137750","display_name":"UC Irvine Health","ror":"https://ror.org/03fgher32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137750"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine C. Coombs","raw_affiliation_strings":["Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, CA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210096636","https://openalex.org/I4210137750","https://openalex.org/I4390039238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060981830","display_name":"Alexandre Chan","orcid":"https://orcid.org/0000-0003-4391-4219","observed_orcids":["https://orcid.org/0000-0003-4391-4219"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210137750","display_name":"UC Irvine Health","ror":"https://ror.org/03fgher32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137750"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre Chan","raw_affiliation_strings":["Department of Pharmacy, University of California Irvine Health, Orange, CA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA; Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, University of California Irvine Health, Orange, CA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA; Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, CA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210137750","https://openalex.org/I4390039238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5100763133"],"corresponding_institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210137750"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":{"value":3890,"currency":"USD","value_usd":3890},"fwci":0.6589,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.67989993,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"25","issue":"12","first_page":"e1014","last_page":"e1021"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/da-epoch-r","display_name":"DA-EPOCH-R","score":0.9929999709129333},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.8650000095367432},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6729999780654907},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9800000190734863},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.7059999704360962},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6100000143051147},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9148065447807312},{"id":"https://openalex.org/C2780317896","wikidata":"https://www.wikidata.org/wiki/Q2703","display_name":"Epoch (astronomy)","level":3,"score":0.9056316614151001},{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.7761870622634888},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.758323073387146},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.5473520755767822},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4600387215614319},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.38966697454452515},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37908944487571716},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3588498830795288},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34422987699508667},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3405115604400635},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C150846664","wikidata":"https://www.wikidata.org/wiki/Q7602306","display_name":"Stars","level":2,"score":0.0},{"id":"https://openalex.org/C1276947","wikidata":"https://www.wikidata.org/wiki/Q333","display_name":"Astronomy","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.clml.2025.06.018","doi":"https://doi.org/10.1016/j.clml.2025.06.018","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clml.2025.06.018","pdf_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/action/showPdf?pii=S2152265025002344","source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},{"id":"doi:10.2139/ssrn.5258232","doi":"https://doi.org/10.2139/ssrn.5258232","is_oa":true,"landing_page_url":"https://doi.org/10.2139/ssrn.5258232","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:13075490","doi":null,"is_oa":true,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40681431/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13075490/pdf/nihms-2157949.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Lymphoma Myeloma Leuk","raw_type":"Text"},{"id":"pmid:40681431","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40681431","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical lymphoma, myeloma & leukemia","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.clml.2025.06.018","doi":"https://doi.org/10.1016/j.clml.2025.06.018","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clml.2025.06.018","pdf_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/action/showPdf?pii=S2152265025002344","source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G9000877839","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA062203","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332688","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4411545401.pdf","grobid_xml":"https://content.openalex.org/works/W4411545401.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W2022229685","https://openalex.org/W2056641238","https://openalex.org/W2058015212","https://openalex.org/W2119147717","https://openalex.org/W2120415962","https://openalex.org/W2126232974","https://openalex.org/W2138504064","https://openalex.org/W2310716991","https://openalex.org/W2478056593","https://openalex.org/W2611828545","https://openalex.org/W2744670476","https://openalex.org/W2902608107","https://openalex.org/W2909854490","https://openalex.org/W2949568806","https://openalex.org/W4389258302"],"related_works":["https://openalex.org/W2025404731","https://openalex.org/W2597156297","https://openalex.org/W3032811388","https://openalex.org/W7220297469","https://openalex.org/W2896058378","https://openalex.org/W3030296130","https://openalex.org/W3169495907","https://openalex.org/W2133869962","https://openalex.org/W2085561179","https://openalex.org/W2594626120"],"abstract_inverted_index":{"BACKGROUND:":[0],"Chemoimmunotherapy":[1],"with":[2,16,42,75,97,193,215],"rituximab":[3,41,53,73,204],"(R)":[4],"added":[5],"to":[6,36],"dose-adjusted":[7],"(DA)-EPOCH":[8],"(continuous":[9],"infusion":[10,186,217],"of":[11,45,72,89,108,127,132],"etoposide,":[12],"vincristine,":[13],"and":[14,18,70,78,103,124,135,150,172,212],"doxorubicin":[15],"cyclophosphamide":[17],"prednisone)":[19],"has":[20],"become":[21],"a":[22],"standard":[23],"treatment":[24,96,210],"approach":[25],"for":[26],"high-risk":[27],"diffuse":[28],"large":[29],"B-cell":[30],"lymphoma":[31],"(DLBCL)":[32],"patients.":[33],"In":[34],"contrast":[35],"pivotal":[37],"trials":[38],"that":[39],"sequenced":[40],"the":[43,68],"initiation":[44,77],"each":[46],"chemoimmunotherapy":[47],"cycle,":[48],"our":[49],"institution":[50],"adopted":[51],"delaying":[52,203],"following":[54,205],"discharge":[55],"after":[56,79],"EPOCH":[57,76,80,206],"completion":[58],"in":[59],"patients":[60,92,138,153,192],"requiring":[61],"inpatient":[62],"chemotherapy":[63],"(DA-EPOCH-R).":[64],"Herein,":[65],"we":[66],"evaluate":[67],"efficacy":[69],"safety":[71],"sequencing":[74],"administration.":[81],"PATIENTS":[82],"AND":[83],"METHODS:":[84],"A":[85,130],"retrospective":[86],"chart":[87],"review":[88],"all":[90],"DLBCL":[91],"who":[93],"received":[94],"first-line":[95],"R-DA-EPOCH":[98,137,151],"or":[99],"DA-EPOCH-R":[100,134,149],"between":[101,148,183],"2016":[102],"2023":[104],"was":[105,144],"conducted.":[106],"Outcomes":[107],"interest":[109],"included":[110],"progression-free":[111],"survival":[112,122],"(PFS),":[113],"overall":[114,121],"response":[115,119],"rate":[116],"(ORR),":[117],"complete":[118],"(CR),":[120],"(OS),":[123],"cumulative":[125],"incidence":[126],"relapse.":[128],"RESULTS:":[129],"total":[131],"31":[133],"35":[136],"were":[139,180,188],"included.":[140],"PFS":[141],"at":[142],"4-years":[143],"not":[145,208],"significantly":[146],"different":[147],"treated":[152],"(75.2%":[154],"vs.":[155,167,175],"77.9%;":[156],"HR":[157],"1.10;":[158],"95%":[159],"CI,":[160],"0.38-3.13;":[161],"P":[162,169,177],"=":[163,170,178,197],".86).":[164],"ORR":[165],"(93.5%":[166],"100%;":[168],".22)":[171],"CR":[173],"(90.3%":[174],"85.7%;":[176],".71)":[179],"also":[181],"similar":[182],"cohorts.":[184],"Rituximab-related":[185],"reactions":[187],"higher":[189],"among":[190],"R-DA-EPOCH-treated":[191],"cycle":[194],"1":[195],"(P":[196],".038).":[198],"CONCLUSION:":[199],"Our":[200],"findings":[201],"suggest":[202],"did":[207],"affect":[209],"outcomes":[211],"are":[213],"associated":[214],"lower":[216],"reactions.":[218]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-10-10T00:00:00"}